IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+3.55%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$349M
AUM Growth
+$349M
Cap. Flow
-$46.8M
Cap. Flow %
-13.39%
Top 10 Hldgs %
42.96%
Holding
198
New
27
Increased
9
Reduced
43
Closed
22

Top Buys

1
KZR icon
Kezar Life Sciences
KZR
$17.1M
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$8.3M
3
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
$6.55M
4
CLDX icon
Celldex Therapeutics
CLDX
$5.75M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.39M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$11.5M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
$7.89M
3
CMPS
Compass Pathways
CMPS
$6.85M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
$6.66M
5
XENE icon
Xenon Pharmaceuticals
XENE
$6.2M

Sector Composition

1 Healthcare 97.67%
2 Consumer Staples 0.57%
3 Technology 0.35%
4 Financials 0.21%
5 Real Estate 0.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KRYS icon
176
Krystal Biotech
KRYS
$4.35B
– –
0
– –
KOD icon
177
Kodiak Sciences
KOD
$453M
– –
0
– –
KNSA icon
178
Kiniksa Pharmaceuticals
KNSA
$2.63B
– –
-59,422
Closed -$677K
IMVT icon
179
Immunovant
IMVT
$2.91B
– –
-83,046
Closed -$722K
ELAN icon
180
Elanco Animal Health
ELAN
$8.62B
– –
0
– –
EDIT icon
181
Editas Medicine
EDIT
$225M
– –
0
– –
DCTH icon
182
Delcath Systems
DCTH
$381M
– –
-44,857
Closed -$468K
CRSP icon
183
CRISPR Therapeutics
CRSP
$4.82B
– –
-27,968
Closed -$3.13M
COGT icon
184
Cogent Biosciences
COGT
$1.83B
– –
-30,727
Closed -$258K
CMPS
185
Compass Pathways
CMPS
$452M
– –
-229,202
Closed -$6.85M
BMRN icon
186
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
0
– –
BCRX icon
187
BioCryst Pharmaceuticals
BCRX
$1.74B
– –
0
– –
BCAB icon
188
BioAtla
BCAB
$28.7M
– –
-196,400
Closed -$5.78M
AZN icon
189
AstraZeneca
AZN
$255B
– –
0
– –
AVIR icon
190
Atea Pharmaceuticals
AVIR
$275M
– –
0
– –
ATHA icon
191
Athira Pharma
ATHA
$15.5M
– –
0
– –
ARKG icon
192
ARK Genomic Revolution ETF
ARKG
$1.05B
– –
-40,961
Closed -$3.06M
APLS icon
193
Apellis Pharmaceuticals
APLS
$3.51B
– –
-347,545
Closed -$11.5M
ALLK
194
DELISTED
Allakos
ALLK
– –
-31,526
Closed -$3.34M
ALDX icon
195
Aldeyra Therapeutics
ALDX
$350M
– –
0
– –
INMB icon
196
INmune Bio
INMB
$52.4M
– –
-26,632
Closed -$517K
NKTR icon
197
Nektar Therapeutics
NKTR
$543M
– –
0
– –
INCY icon
198
Incyte
INCY
$17B
– –
-32,666
Closed -$2.25M
4 5 6 7
8